Chemoinformaics analysis of 2,4-Dimethylhexane
| Molecular Weight | 114.232 | nRot | 3 |
| Heavy Atom Molecular Weight | 96.088 | nRig | 1 |
| Exact Molecular Weight | 114.141 | nRing | 0 |
| Solubility: LogS | -6.13 | nHRing | 0 |
| Solubility: LogP | 6.402 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 25.3623 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.337 |
| Synth | 2.705 |
| Natural Product Likeliness | 0.594 |
| NR-PPAR-gamma | 0.922 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.886 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.593 |
| MDCK | 0.000016 |
| BBB | 0.198 |
| PPB | 0.979757 |
| VDSS | 1.987 |
| FU | 0.0133557 |
| CYP1A2-inh | 0.24 |
| CYP1A2-sub | 0.324 |
| CYP2c19-inh | 0.513 |
| CYP2c19-sub | 0.092 |
| CYP2c9-inh | 0.236 |
| CYP2c9-sub | 0.919 |
| CYP2d6-inh | 0.222 |
| CYP2d6-sub | 0.13 |
| CYP3a4-inh | 0.637 |
| CYP3a4-sub | 0.113 |
| CL | 4.05 |
| T12 | 0.04 |
| hERG | 0.157 |
| Ames | 0.007 |
| ROA | 0.016 |
| SkinSen | 0.628 |
| Carcinogencity | 0.512 |
| EI | 0.96 |
| Respiratory | 0.963 |
| NR-Aromatase | 0.051 |
| Antiviral | No |
| Prediction | 0.938385 |